UNSPSC 51313441: Triprolidine hydrochloride anhydrous

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H22N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NG7A104R3J, chemically known as (e)-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine monohydrochloride, but more generally known as triprolidine hydrochloride anhydrous, which bears US NIH Compound Identifier 5702129.

European Medicines Agency schedules triprolidine hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11323MIG. Most nations, for tariff purposes, schedule triprolidine hydrochloride anhydrous under HS 29333999. SMILES: CC1CCC(CC1)/C(=C\CN2CCCC2)/C3CCCCN3.CL.

UNSPSC 51313441 Triprolidine hydrochloride anhydrous is a Commodity code that does not align with the recent state and local contract opportunities posted under it. The three most recent opportunities—Seminole County's procurement of naloxone and drug deactivation systems, the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products—concern naloxone distribution, pharmacy benefit management infrastructure, and broad generic pharmaceutical supply contracts. None of these solicitations specifically reference triprolidine hydrochloride anhydrous or antihistamine products. The code shows minimal relevant recent activity for a business development professional evaluating actual state and local demand for triprolidine hydrochloride anhydrous.

The mismatch between the code's nominal scope and the posted opportunities suggests that triprolidine hydrochloride anhydrous either sees limited direct procurement by state and local health agencies, is acquired as part of larger pharmaceutical supply contracts where the specific active pharmaceutical ingredient is not tagged at the commodity level, or is misclassified in the underlying opportunity records. Procurement professionals pursuing this code should verify whether state and local health departments, county health systems, or other public health entities are actually soliciting triprolidine hydrochloride anhydrous as a line-item purchase or whether the drug is sourced indirectly through cooperative purchasing frameworks or generic pharmaceutical supply agreements that aggregate multiple active ingredients under higher-tier UNSPSC categories.